Total Payments
$2,429
2024 Payments
$1,973
Companies
11
Transactions
68
Payment Breakdown by Category
Food & Beverage$2,429 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,429 | 68 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $656.48 | 11 | $0 (2024) |
| Amgen Inc. | $456.12 | 10 | $0 (2024) |
| Gilead Sciences, Inc. | $432.42 | 5 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $318.83 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $181.36 | 10 | $0 (2024) |
| Novo Nordisk Inc | $175.38 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $102.66 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $42.42 | 2 | $0 (2024) |
| PFIZER INC. | $27.58 | 2 | $0 (2024) |
| Inspire Medical Systems, Inc. | $22.24 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,973 | 53 | AstraZeneca Pharmaceuticals LP ($476.40) |
| 2023 | $456.09 | 15 | AstraZeneca Pharmaceuticals LP ($180.08) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Cardio-renal | ||||||
| 11/08/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: Bone Health | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: VACCINE | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.44 | General |
| 10/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Cardio-renal | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $93.66 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $127.72 | General |
| Category: Inflammation | ||||||
| 09/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.13 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: DIABETES | ||||||
| 09/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: DIABETES | ||||||
| 08/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Cardio-renal | ||||||
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: DIABETES | ||||||
| 08/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Cardio-renal | ||||||
| 08/08/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: NEUROLOGY | ||||||
| 08/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Obesity | ||||||
About Ravy Sun, RN
Ravy Sun, RN is a Medical-Surgical healthcare provider based in Richardson, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2021. The National Provider Identifier (NPI) number assigned to this provider is 1083378996.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ravy Sun, RN has received a total of $2,429 in payments from pharmaceutical and medical device companies, with $1,973 received in 2024. These payments were reported across 68 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($2,429).
Ad
Practice Information
- Specialty Medical-Surgical
- Other Specialties Primary Care
- Location Richardson, TX
- Active Since 10/26/2021
- Last Updated 02/07/2024
- Taxonomy Code 163WM0705X
- Entity Type Individual
- NPI Number 1083378996
Products in Payments
- Otezla (Drug) $446.48
- BREZTRI (Drug) $405.26
- Kerendia (Drug) $318.83
- JARDIANCE (Drug) $181.36
- FARXIGA (Drug) $142.14
- Epclusa (Drug) $141.40
- Vemlidy (Drug) $125.69
- AIRSUPRA (Drug) $109.08
- SHINGRIX (Biological) $72.31
- Rybelsus (Drug) $55.59
- Ozempic (Drug) $51.92
- Wegovy (Drug) $49.76
- AREXVY (Drug) $30.35
- NURTEC ODT (Drug) $27.58
- DIFICID (Drug) $22.71
- INSPIRE (Device) $22.24
- GARDASIL (Biological) $19.71
- MOUNJARO (Drug) $13.51
- EVENITY (Biological) $9.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.